classified Biocon Biologics' insulin facilities in Johor Bahru, Malaysia, as Voluntary Action Indicated (VAI). “This relates to the cGMP inspection conducted by the agency between September 15–27, ...

Shares of Biocon soared over 4 percent on January 13 after the US Food and Drug Administration cleared arm Biocon Biologics' insulin facility in Malaysia, putting an end to a major regulatory ...

Shares of Biocon were in high demand on Monday after the pharmaceutical company’s subsidiary Biocon Biologics’ Johor Bahru facility in Malaysia was classified as "Voluntary Action Indicated" (VAI) by ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

The upgrade reflects a turnaround driven by biosimilar launches, improved generics sales, and US FDA clearance of Biocon’s Malaysia plant. HSBC's new target price represents a 48.3% increase, ...

Shares of Biocon Ltd surged as much as 5 per cent during the trading session on Monday after the United States Food and Drug Administration (USFDA) cleared the Malaysia unit, ending regulatory ...

SBI Multi Asset Allocation Fund (G) 15.92 4,16,589 0.23 SBI Multi Asset Allocation Fund (IDCW-M) 15.92 4,16,589 0.23 SBI Multi Asset Allocation Fund (IDCW-Q) 15.92 4 ...

Biocon Ltd share price was down by -4.64% from the previous closing price of ₹388.25. Who are peers of Biocon Ltd? The peers of Biocon Ltd are Sun Pharmaceuticals Industries Ltd, Divis ...

Bengaluru: Biocon has announced that the U.S. Food and Drug Administration (FDA) has classified Biocon Biologics' Insulins facilities in Johor Bahru, Malaysia as Voluntary Action Indicated (VAI). This ...

HSBC noted that Biocon is well-positioned for growth, citing key developments such as the FDA clearance for its Malaysia insulin plant, which ends a long regulatory overhang and paves the way for the ...

The shares of Biocon Ltd. rose over 4% on Monday after the U.S. Food and Drug Administration cleared its subsidiary's facilities in Malaysia. The US drug regulator has given a 'Voluntary Action ...

Biocon Ltd. will be in focus on Monday, January 13, after the Biocon Biologics' insulin facility in Johor Bahru was classified as a "Voluntary Action Indicated" (VAI) by the USFDA. The facility was ...